Details for New Drug Application (NDA): 214287
✉ Email this page to a colleague
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for 214287
Tradename: | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
Applicant: | Quagen |
Ingredient: | acetaminophen; butalbital; caffeine |
Patents: | 0 |
Pharmacology for NDA: 214287
Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 214287
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 214287 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-142 | 70752-142-10 | 100 TABLET in 1 BOTTLE, PLASTIC (70752-142-10) |
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | TABLET;ORAL | 214287 | ANDA | QUAGEN PHARMACEUTICALS LLC | 70752-142 | 70752-142-14 | 500 TABLET in 1 BOTTLE, PLASTIC (70752-142-14) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 325MG;50MG;40MG | ||||
Approval Date: | Jan 18, 2024 | TE: | AA | RLD: | No |
Complete Access Available with Subscription